DrugPatentWatch Database Preview
Drugs in Development Information for Dolastatin 10
» See Plans and Pricing
What is the drug development status for Dolastatin 10?
Dolastatin 10 is an investigational drug.
There have been 7 clinical trials for Dolastatin 10.
The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 1999.
The most common disease conditions in clinical trials are Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, and Carcinoma, Renal Cell. The leading clinical trial sponsors are National Cancer Institute (NCI), M.D. Anderson Cancer Center, and Barbara Ann Karmanos Cancer Institute.
Summary for Dolastatin 10
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 52 |
| WIPO Patent Applications | 1,639 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (1999-01-01) |
| Vendors | 16 |
Recent Clinical Trials for Dolastatin 10
| Title | Sponsor | Phase |
|---|---|---|
| Dolastatin 10 in Treating Patients With Advanced Kidney Cancer | National Cancer Institute (NCI) | Phase 2 |
| Dolastatin 10 in Treating Patients With Advanced Kidney Cancer | Mayo Clinic | Phase 2 |
| Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma | National Cancer Institute (NCI) | Phase 2 |
Clinical Trial Summary for Dolastatin 10
Top disease conditions for Dolastatin 10
Top clinical trial sponsors for Dolastatin 10
US Patents for Dolastatin 10
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
